Literature DB >> 8649788

Epitope analysis of the murine p53 tumour suppressor protein.

D P Lane1, C W Stephen, C A Midgley, A Sparks, T R Hupp, D A Daniels, R Greaves, A Reid, B Vojtesek, S M Picksley.   

Abstract

The identification and characterisation of the p53 tumour suppressor has relied extensively on the use of immunological reagents. To facilitate further characterisation of the murine p53 protein (Mp53), and its interaction with other proteins, we have characterised the antigenic sites of Mp53 in fine detail. Using an overlapping Mp53 peptide library we report the identification by Pepscan ELISA of the epitopes of nine antibodies. We have also used this technique to determine whether corresponding epitopes were present in a human p53 (Hp53) peptide library. This comparison was extended to include polyclonal sera of mice immunized with either Mp53 or Hp53, to compare the overall range of antigenic sites. The range of antigenic sites identified by polyclonal sera is very similar, although the N-terminus of Mp53 is clearly not an immunodominant region, in contrast to the N-terminus of Hp53. However, the N-terminus of Mp53 is immunogenic in rabbits as demonstrated by the Pepscan ELISA of CM5 serum (a rabbit anti-Mp53 serum used in analysing p53 expression in mice). Since, very few new antigenic sites were identified in either Mp53 or Hp53, new approaches will have to be employed to identify novel immunological reagents against human and murine p53.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649788

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.

Authors:  F Janus; N Albrechtsen; U Knippschild; L Wiesmüller; F Grosse; W Deppert
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection.

Authors:  W Henning; G Rohaly; T Kolzau; U Knippschild; H Maacke; W Deppert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs.

Authors:  Erica Ungewitter; Heidi Scrable
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

4.  Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA.

Authors:  D Parks; R Bolinger; K Mann
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

5.  The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF).

Authors:  S E Seavey; M Holubar; L J Saucedo; M E Perry
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  Effects of 2-amino-4,6-dinitrotoluene on p53 tumor suppressor gene expression.

Authors:  Hirendra Banerjee; Zack Hawkins; Sisir Dutta; Duane Smoot
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

7.  Inappropriate p53 activation during development induces features of CHARGE syndrome.

Authors:  Jeanine L Van Nostrand; Colleen A Brady; Heiyoun Jung; Daniel R Fuentes; Margaret M Kozak; Thomas M Johnson; Chieh-Yu Lin; Chien-Jung Lin; Donald L Swiderski; Hannes Vogel; Jonathan A Bernstein; Tania Attié-Bitach; Ching-Pin Chang; Joanna Wysocka; Donna M Martin; Laura D Attardi
Journal:  Nature       Date:  2014-08-03       Impact factor: 49.962

8.  Activation of caspases in p53-induced transactivation-independent apoptosis.

Authors:  C Gao; N Tsuchida
Journal:  Jpn J Cancer Res       Date:  1999-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.